 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Agatha Jassem | |
|---|---|
| Nationality | Canadian |
| Alma mater | University of British Columbia |
| Occupation | clinical microbiologist |
Agatha Jassem is a Canadian clinical microbiologist and the program head of the Virology Lab at the British Columbia Centre for Disease Control Public Health Laboratory,[1] and a clinical associate professor in the Department of Pathology & Laboratory Medicine at the University of British Columbia in Vancouver, British Columbia, Canada.[2]
Jassem obtained her PhD at the University of British Columbia, followed by a fellowship in Clinical Microbiology at the National Institutes of Health.[3] Her research focuses the detection of healthcare-and community-associated infections, emerging pathogens, and drug resistance determinants.
During the COVID-19 pandemic response, Jassem led research efforts on COVID-19 breakthrough infections from vaccinated individuals,[4][5] SARS-CoV-2 population level seroprevalence,[6] antibody response [7] as well as collaborating on research on securing reagents for COVID-19 during world-wide shortages,[8] and the role of ACEII. [9]
- ^ "Agatha Jassem". bccdc.ca. Retrieved 2021-09-20.
- ^ "Agatha Jassem". Pathology. Retrieved 2021-09-20.[permanent dead link]
- ^ "Agatha Jassem". Pathology. Retrieved 2021-09-20.[permanent dead link]
- ^ "COVID-19 Smiles – The Study of Vaccine Escape Mutants | COVID-19 Research". covid19.research.ubc.ca. Retrieved 2021-09-20.
- ^ "COVID-19 research initiatives at UBC among those funded by first-time partnership". UBC Faculty of Medicine. 2021-05-21. Retrieved 2021-09-28.
- ^ "Population-Based Study Of Coronavirus Antibody Cross-Reactivity To Inform SARS-CoV-2 Seroprevalence | COVID-19 Research". covid19.research.ubc.ca. Retrieved 2021-09-20.
- ^ "Characterizing Antibody Response to Emerging COVID-19 Virus (CARE COVID-19) | COVID-19 Research". covid19.research.ubc.ca. Retrieved 2021-09-20.
- ^ "Securing Reagent Supplies and Scaling COVID-19 | COVID-19 Research". covid19.research.ubc.ca. Retrieved 2021-09-20.
- ^ "Prognostication of ACE II Receptor (PACEiiR) | COVID-19 Research". covid19.research.ubc.ca. Retrieved 2021-09-20.